Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
Paediatric Haematology-Oncology Program, Research Centre, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Leukemia. 2018 Sep;32(9):1984-1993. doi: 10.1038/s41375-018-0046-8. Epub 2018 Mar 20.
Single-cell genetics were used to interrogate clonal complexity and the sequence of mutational events in STIL-TAL1+ T-ALL. Single-cell multicolour FISH was used to demonstrate that the earliest detectable leukaemia subclone contained the STIL-TAL1 fusion and copy number loss of 9p21.3 (CDKN2A/CDKN2B locus), with other copy number alterations including loss of PTEN occurring as secondary subclonal events. In three cases, multiplex qPCR and phylogenetic analysis were used to produce branching evolutionary trees recapitulating the snapshot history of T-ALL evolution in this leukaemia subtype, which confirmed that mutations in key T-ALL drivers, including NOTCH1 and PTEN, were subclonal and reiterative in distinct subclones. Xenografting confirmed that self-renewing or propagating cells were genetically diverse. These data suggest that the STIL-TAL1 fusion is a likely founder or truncal event. Therapies targeting the TAL1 auto-regulatory complex are worthy of further investigation in T-ALL.
单细胞遗传学被用于探究 STIL-TAL1+ T-ALL 的克隆复杂性和突变事件的顺序。单细胞多色 FISH 用于证明最早可检测到的白血病亚克隆包含 STIL-TAL1 融合和 9p21.3(CDKN2A/CDKN2B 基因座)的拷贝数缺失,其他拷贝数改变包括 PTEN 缺失作为次要亚克隆事件发生。在三种情况下,使用多重 qPCR 和系统发育分析生成分支进化树,重现该白血病亚型 T-ALL 进化的快照历史,证实关键 T-ALL 驱动基因(包括 NOTCH1 和 PTEN)的突变是亚克隆的,并且在不同的亚克隆中重复出现。异种移植证实自我更新或增殖的细胞具有遗传多样性。这些数据表明,STIL-TAL1 融合可能是创始或主干事件。针对 TAL1 自身调节复合物的治疗方法值得在 T-ALL 中进一步研究。